ResearcherSecond Military Medical UniversityActive in the last 2 years
Wei Wang
Matched on ORCID iD 0000-0001-6853-7785; OpenAlex author ID A5100391700. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 2 papers · 2025: none · 2026: 1 paper
Papers 5
- Machine-learning CT radiomics for prognostication in unresectable pancreatic cancer. Co-author DOI 10.3389/fphar.2026.1750762↗
- Prediction of postoperative liver metastasis in pancreatic ductal adenocarcinoma based on multiparametric magnetic resonance radiomics combined with serologica… Co-author DOI 10.1007/s00261-023-04047-0↗
- Anti-PD-L1 checkpoint inhibitor combined with nanocarrier-mediated cisplatin codelivery system for effective treatment of pancreatic cancer. Co-author DOI 10.1016/j.molimm.2024.08.006↗
- Downregulation of miR-486-5p Enhances the Anti-Tumor Effect of 5-Fluorouracil on Pancreatic Cancer Cells. Co-author DOI 10.2147/ott.s231153↗
- Downregulation of miR-183 inhibits the growth of PANC-1 pancreatic cancer cells in vitro and in vivo, and increases chemosensitivity to 5-fluorouracil and gemc… First author DOI 10.3892/etm.2018.7112↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Min Luo · 1 shared paper, 2026 · strength 0.30
- Wenqi He · 1 shared paper, 2026 · strength 0.30
- Zhou-Yan Jia · 1 shared paper, 2024 · strength 0.26
- Bang‐Le Zhang · 1 shared paper, 2024 · strength 0.26
- Zhongyu Yuan · 1 shared paper, 2024 · strength 0.22
- Jianguo Zhong · 1 shared paper, 2024 · strength 0.22
- Zhao‐Shen Li · 1 shared paper, 2020 · strength 0.12
- Bowei Liu · 1 shared paper, 2020 · strength 0.12
- Shuangyin Han · 1 shared paper, 2020 · strength 0.12
- Bo Yu · 1 shared paper, 2019 · strength 0.11
- Qi Zou · 1 shared paper, 2019 · strength 0.11
- Xiaoping Yang · 1 shared paper, 2019 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.